Skip directly to search Skip directly to A to Z list Skip directly to page options Skip directly to site content

Volume 19, Number 3—March 2013

Letter

Mycobacterium fortuitum Endocarditis Associated with Cardiac Surgery, Serbia

Suggested citation for this article

To the Editor: Mycobacterium fortuitum is a member of the group of rapidly growing nontuberculous mycobacteria. It is a well-known causative agent of skin and soft tissue infections, postsurgical wound infections, and other health care–associated infections (1). Only sporadic cases of endocarditis caused by this bacterium have been reported (24). We describe a cardiac surgery–related outbreak of endocarditis caused by M. fortuitum in 3 children.

Over a 3-week period during 2009, eight children consecutively underwent surgery for correction of ventricular septal defect (VSD) by insertion of a bovine pericardial patch at the University Children’s Hospital in Belgrade, Serbia. None of them had previous cardiac surgery. The same patch, SJM Pericardial Patch with EnCap Technology (St. Jude Medical, St. Paul, MN, USA), was used as a source for smaller, tailored patches for all patients. Sterile scissors and forceps were used to tailor a piece of the patch needed for a corresponding VSD closure. During repeated performances of this procedure and between surgeries, the patch had been continuously stored in 2% propylene oxide (PO) provided by the manufacturer. Each tailored piece of the patch had been immersed into freshly prepared sterile saline for 6 min before defect patching. The postoperative course had been uneventful for all patients, and they were discharged 7 days after the procedure. However, 3 patients were readmitted to the hospital because of prolonged fever and increasing fatigue. Patients 1, 2, and 3 (Table) had been the fourth, sixth, and eighth patients undergoing VSD repair, respectively. Diagnosis of infective endocarditis in these patients was established by transthoracic echocardiography findings and blood cultures positive for acid-fast bacteria (Table). Acid-fast bacteria also were recovered from the patch and vegetation taken during reoperation in patient 3 (Table). The isolates were identified as M. fortuitum by the GenoType Mycobacterium CM assay (Hain Lifescience, Nehren, Germany) (5). Empiric treatment with vancomycin and ceftriaxone was switched to amikacin, ciprofloxacin, and imipenem. After 6 weeks of treatment, the patients were discharged, and all were asymptomatic 12 months later.

The cultural characteristics and susceptibility patterns of all the isolates obtained were indistinguishable. To explore their possible clonal relatedness, we genotyped 3 M. fortuitum strains isolated from blood cultures (1 isolate per patient) and 2 M. fortuitum isolates recovered from samples taken during reoperation in 1 of the patients. The enterobacterial repetitive intergenic consensus PCR was used (6), and all isolates produced identical patterns.

Nosocomially acquired M. fortuitum endocarditis has been reported but only sporadically in adults, and these cases usually were fatal (3,4,7). In contrast, we describe 3 related cases of M. fortuitum endocarditis in children who recovered. The relatedness of the cases is strongly supported by the following. First, epidemiologic links are obvious because the 3 patients underwent surgery in the same operating room, and the same patch was used in all of them. Second, M. fortuitum strains isolated from the 3 patients were phenotypically and genotypically identical.

Repeated use of the same patch in multiple surgeries strongly suggests the contaminated patch was the source of M. fortuitum infection in the 3 patients. This possibility could not be corroborated by bacteriologic examination of the patch because the remaining unusable fragments had been discarded after the surgeries (i.e., ≈3 months before the outbreak became evident). Although contamination of the patch during manufacture is possible (8), it seems more reasonable to assume that the contamination occurred intraoperatively. The common factor in nosocomially acquired M. fortuitum infections is presumed to be exposure to a liquid contaminated with this organism (1,9). The patch was not exposed to solutions other than the PO in which it had been stored and the sterile saline used during the rinsing procedure. Because only a piece of the patch tailored for a particular patient was exposed to a saline freshly prepared for each surgery, contamination of the PO by M. fortuitum presumably led to contamination of the patch. Liquid PO is used as a chemical sterilant for bioprostheses intended for single use. However, multiple use of the same patch implied repeated exposure of the PO solution to the environment and prolonged storage at 4°C between surgeries. Because PO effectiveness is markedly reduced at temperatures <16°C (10), the specific circumstances could have compromised the sterilizing capacity of the PO solution and enabled contamination by ubiquitous M. fortuitum.

We are well aware that the patch was intended for single use only and that application of the same patch in multiple patients is not a practice in industrialized countries. However, it is a practice in some resource-limited countries. The outbreak of M. fortuitum endocarditis we describe is a clear warning that such practice is associated with high risk and thus should be discontinued.

Dragana VukovićComments to Author , Vojislav Parezanović, Branislava Savić, Ivana Dakić, Suzana Laban-Nestorović, Slobodan Ilić, Ivana Ćirković, and Srdjan Stepanović
Author affiliations: Author affiliations: University of Belgrade, Belgrade, Serbia (D. Vuković, V. Parezanović, B. Savić, I. Dakić, S. Ilić, I. Ćirković, S. Stepanović); University Children's Hospital, Belgrade (V. Parezanović, S. Laban-Nestorović, S. Ilić)

Acknowledgment

The work of D.V., I.D., B.S., and I.Ć. was supported by project grant no. 175039 from the Ministry of Education and Science, Republic of Serbia.

References

  1. Griffith DE, Aksamit T, Brown-Elliot BA, Catanzaro A, Daley C, Gordin F, An official ATS/IDSA statement: diagnosis, treatment, and prevention of nontuberculous mycobacterial diseases. [Erratum in: Am J Respir Crit Care Med. 2007;175:744–5. ]. Am J Respir Crit Care Med. 2007;175:367416. DOIPubMed
  2. Spell DW, Szurgot JG, Greer RW, Brown JW. Native valve endocarditis due to Mycobacterium fortuitum biovar fortuitum: case report and review. Clin Infect Dis. 2000;30:6056. DOIPubMed
  3. Kunin M, Salamon F, Weinberger M, Genkin I, Sagie A, Tur-Kaspa R. Conservative treatment of prosthetic valve endocarditis due to Mycobacterium fortuitum. Eur J Clin Microbiol Infect Dis. 2002;21:53941. DOIPubMed
  4. Olalla J, Pombo M, Aguado JM, Rodríguez E, Palenque E, Costa JR, Mycobacterium fortuitum complex endocarditis-case report and literature review. Clin Microbiol Infect. 2002;8:1259. DOIPubMed
  5. Richter E, Rüsch-Gerdes S, Hillemann D. Evaluation of the GenoType Mycobacterium assay for identification of mycobacterial species from cultures. J Clin Microbiol. 2006;44:176975. DOIPubMed
  6. Sampaio JL, Chimara E, Ferrazoli L, da Silva Telles MA, Del Guercio VM, Jerico ZV, Application of four molecular typing methods for analysis of Mycobacterium fortuitum group strains causing post-mammaplasty infections. Clin Microbiol Infect. 2006;12:1429. DOIPubMed
  7. Sharma S, Tleyjeh IM, Espinosa RE, Costello BA, Baddour LM. Pacemaker infection due to Mycobacterium fortuitum. Scand J Infect Dis. 2005;37:667. DOIPubMed
  8. Strabelli TMV, Siciliano RF, Castelli JB, Demarchi LM, Leão SC, Viana-Niero C, Mycobacterium chelonae valve endocarditis resulting from contaminated biological prostheses. J Infect. 2010;60:46773. DOIPubMed
  9. Wallace RJ Jr, Brown BA, Griffith DE. Nosocomial outbreaks/pseudo-outbreaks caused by nontuberculous mycobacteria. Annu Rev Microbiol. 1998;52:45390. DOIPubMed
  10. Wright RC. The sterilizing capacity of propylene oxide and chlorhexidine diacetate solutions upon pre-injection swabs saturated with propan-2-ol. J Hyg (Lond). 1983;91:28792. DOIPubMed

Table

Suggested citation for this article: Vuković D, Parezanović V, Savić B, Dakić I, Laban-Nestorović S, Ilić S, et al. Mycobacterium fortuitum endocarditis associated with cardiac surgery, Serbia [letter]. Emerg Infect Dis [Internet]. 2013 Mar [date cited]. http://dx.doi.org/10.3201/eid1903.120763

DOI: 10.3201/eid1903.120763

Related Links

Table of Contents – Volume 19, Number 3—March 2013

Comments

Please use the form below to submit correspondence to the authors or contact them at the following address:

Dragana Vuković, Institute of Microbiology and Immunology, Faculty of Medicine, University of Belgrade, dr Subotića 1, 11000 Belgrade, Serbia


character(s) remaining.

Comment submitted successfully, thank you for your feedback.

TOP